EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single‐cell transcriptomics reveals antigen‐presenting capacity and therapeutic resistance potential of immunomodulatory endothelial cells in colorectal cancer

Jingyi Wen iD

Immunity, Inflammation and Disease · 2024-06 · 12 (6)

DOI: 10.1002/iid3.1311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 14.06.2024. Verfasst von Jingyi Wen. Beteiligte Einrichtung: School of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Endothelial Cells, Single-Cell Analysis, Transcriptome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The heterogeneity of tumor endothelial cells (TECs) hinders the efficacy of antiangiogenic therapies (AATs). Only a small percentage of angiogenic TECs are considered effective targets for AATs. Immunomodulatory ECs (IMECs), as a newly focused functional subgroup of endothelial cells (ECs), are being evaluated for their ability to regulate tumor immune balance and influence existing AATs.

Methods

Based on single‐cell transcriptome data from colorectal cancer in a publicly available database, we conducted a wide array of bioinformatic approaches to study EC subsets that meet the IMECs definition. Our investigation encompassed the gene expression signatures of these subsets, cellular composition differences, cell–cell interactions.

Results

Two subsets that meet the IMECs definition were found in tumors and para‐cancerous tissues. Combined with the results of gene ontological analysis and interaction with CD4 + T cells, we found that IMECs can present MHC‐II antigens to mature CD4 + T cells. There were differences in the level of interaction between IMECs and different types of mature CD4 + T cell subsets. In addition, IMEC subsets had different expression levels of angiogenesis related genes. The angiogenesis score of IMECs decreased after patients received immunotherapy. IMEC subsets do not depend on a single proangiogenic receptor and are involved in regulating angiogenesis, which may reduce the efficacy of AATs. The adverse effects of specific IMEC subsets on AATs were validated in the RNA‐seq dataset of the bevacizumab treatment group.

Conclusion

Our study suggests the potential MHC‐II antigen presentation capacity of IMECs and the enhanced angiogenesis characteristics within tumors. The function of IMECs in the vascular network may have a potentially adverse effect on AATs. Controlling the functional properties of IMECs may be a new angle for tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEndothelial CellsSingle-Cell AnalysisTranscriptomeHumansAntigen PresentationNeovascularization, PathologicDrug Resistance, NeoplasmGene Expression ProfilingAngiogenesis InhibitorsImmunomodulationCD4-Positive T-Lymphocytes

Stichwörter der Autor:innen

angiogenesisantiangiogenic therapiesantigen presentationcolorectal cancerimmunomodulatorytumor endothelial cells

Substanzen

Angiogenesis Inhibitors

Autor:innen und Institutionen

  • School of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong, China.

ORCID-Profile: Jingyi Wen

Zitieren

APA

Wen, J. (2024). Single‐cell transcriptomics reveals antigen‐presenting capacity and therapeutic resistance potential of immunomodulatory endothelial cells in colorectal cancer. Immunity, Inflammation and Disease, 12(6). https://doi.org/10.1002/iid3.1311

Vancouver

Wen J. Single‐cell transcriptomics reveals antigen‐presenting capacity and therapeutic resistance potential of immunomodulatory endothelial cells in colorectal cancer. Immunity, Inflammation and Disease. 2024;12(6). doi:10.1002/iid3.1311

BibTeX
@article{Wen2024,
  author = {Wen, Jingyi},
  title = {Single‐cell transcriptomics reveals antigen‐presenting capacity and therapeutic resistance potential of immunomodulatory endothelial cells in colorectal cancer},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  volume = {12},
  number = {6},
  doi = {10.1002/iid3.1311}
}
Kostenlos starten →